The move was essentially a reverse merger to bring Viventia into the public arena quickly and easily, and while the name remains Eleven (likely a ...
Growth Capitalist (https://growthcapitalist.com/2016/11/eleven-biotherapeutics-inc-nasdaqebio-rockets-heres-whats-next/)
The move was essentially a reverse merger to bring Viventia into the public arena quickly and easily, and while the name remains Eleven (likely a ...